justifies. In contrast to what they suggest, the false negative rate of lymphatic mapping leaves a lot to be desired. Rates of false negative results, determined by concomitant completion lymphadenectomy, were indeed reported to be approximately 5%. [1, 2, 3, 4] This percentage concerns the fraction of node positive patients with a false negative sentinel node procedure.
The authors state that these findings were corroborated by studies that showed nodal recurrence rates ranging from 3% to 6% in patients with tumor-negative sentinel nodes.
However, patients with tumor-negative sentinel nodes are a different patient population.
Since only 20% of the patients have involved nodes, the actual false negative rate is more than five times higher than the suggested 3% to 6%.(5) Also, the duration of follow up in two of the three quoted studies is too short too allow a definitive assessment of the false negative rate, because a recurrence in the nodal basin becomes evident after a median time frame of 28 months. [6, 7, 8] 
